Advanced Filters
noise
Found 2,152 clinical trials
A Astrid Leusink

MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapy

Patients who require a removal of a breast (mastectomy) for breast cancer or future risk reduction often have immediate breast reconstruction (IBR). This can be performed using either an implant or the patient's own body fat to recreate the breast shape. Patients can find it difficult to imagine their own …

18 years of age Female Phase N/A

Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence

The aim of this clinical trial is to assess the feasibility of training a device capable of distinguishing various gases emitted by tissues cauterized by an electrosurgical unit during a breast cancer resection surgery. The patients to be enrolled will be women over 18 years old diagnosed with breast cancer …

18 years of age Female Phase N/A
D Dede Teteh-Brooks, DRPH

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors. A community-based and peer-led Black Breast Cancer Survivors Intervention (BBCSI) course has been developed to help improve the quality of life of Black breast …

18 years of age All Phase N/A
G Gong Chang, doctor

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

This is a cross-sectional and an observational study, investigator-initiated study in HER2-low breast cancer patients. Approximately 255 subjects with HRD (homologous recombination deficiency) assessment will be enrolled in this study to examine the distribution and features of HRD/HRR (homologous recombination repair). In this study, investigators plan to clarify the frequency …

18 - 70 years of age Female Phase N/A
Z Zheng Lv

Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer

This is an observational clinical study of MRD as a predictor of local treatment in patients with oligometastatic breast cancer. The aim of the study is to assess the correlation between MRD levels and prognosis in patients with oligometastatic breast cancer who have undergone local treatment in order to identify …

years of age All Phase N/A

Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

This study aims to evaluate the diagnostic accuracy (sensitivity, specificity, positive/negative predictive value, and overall accuracy) of 18F-FAPI-04 PET imaging in breast cancer for detecting fibroblast activation protein (FAP)-rich lesions. Additionally, the study will longitudinally monitor dynamic changes in FAP expression levels and tumor size during therapy, including chemotherapy, targeted …

18 - 75 years of age All Phase N/A
P Peng Yuan

Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy

Breast cancer has become the world's number one cancer. While its therapeutic efficacy is increasing, how to achieve non-invasive evaluation of the efficacy of neoadjuvant therapy (NAT) for breast cancer patients and thus avoid surgery has become a bottleneck problem that needs to be broken through in clinical diagnosis and …

18 years of age Female Phase N/A
F Farida Arjuman, FCPS, MCPS

AI Model for Classifying Breast Cancer From Histopathology Images

Breast cancer, a prevalent and potentially fatal disease, underscores the need for early and accurate detection to improve patient outcomes. Traditional histopathological examination, the current gold standard for diagnosis, faces limitations like subjectivity and low efficiency. In response, this research seeks to revolutionize breast cancer diagnostics by using deep learning …

years of age Female Phase N/A
L Li Ya Xu, PhD

Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade

Explore VOCs indicators that can effectively distinguish between benign and malignant breast diseases. The accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.

18 - 80 years of age Female Phase N/A
L Lei Dou, Dr.

An In-situ Detection for MicroRNA

We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.

18 - 75 years of age Female Phase N/A

Simplify language using AI